Immunogenomic analyses associate immunological alterations with mismatch repair defects in prostate cancerDaniel Nava Rodrigues, Charles G. Drake, Suzanne Carreira et al.|Journal of Clinical Investigation|2018Cited by 209
1662TiP HARMONY: A phase II study of niraparib (N)/abiraterone acetate (AA) plus prednisone (P) for Hispanic/Latino (HL) and non-Hispanic Black (NHB) patients (pts) with metastatic hormone sensitive prostate cancer (mHSPC) and deleterious homologous recombination repair alterations (HRRa)Q. Qin, Tingwei Zhang, Shaofeng Zhang et al.|Annals of Oncology|2024Cited by 0